Huaixin Xing
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 4
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery 2
-
- RNA modifications and cancer 5
- Cancer-related gene regulation 4
- RNA Research and Splicing 3
-
- Peptidase Inhibition and Analysis 2
-
- Genetic factors in colorectal cancer 2
-
- Cancer, Stress, Anesthesia, and Immune Response 2
- Partner nations
- ChinaUnited States
In The Last Decade
Huaixin Xing
20 papers receiving 650 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 326
- Pharmaceutical Science 51
- Molecular Biology 437
- Biomaterials 80
- Oncology 80
Countries citing papers authored by Huaixin Xing
This map shows the geographic impact of Huaixin Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaixin Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaixin Xing more than expected).
Fields of papers citing papers by Huaixin Xing
This network shows the impact of papers produced by Huaixin Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaixin Xing. The network helps show where Huaixin Xing may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huaixin Xing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 12 | |
| 5 | 2021 | 10 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 16 | |
| 8 | 2020 | 84 | |
| 9 | 2020 | 24 | |
| 10 | 2020 | 11 | |
| 11 | 2019 | 246 | |
| 12 | 2019 | 11 | |
| 13 | 2017 | 8 | |
| 14 | 2017 | 9 | |
| 15 | 2017 | 22 | |
| 16 | 2017 | 48 | |
| 17 | 2016 | 17 | |
| 18 | 2014 | 5 | |
| 19 | 2014 | 48 | |
| 20 | 2014 | 71 |
About Huaixin Xing
Huaixin Xing is a scholar working on Cancer Research, Pharmaceutical Science and Developmental Neuroscience, having authored 20 papers that have together received 656 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer-related gene regulation (4 papers), RNA Research and Splicing (3 papers), Advancements in Transdermal Drug Delivery (2 papers), Genetic factors in colorectal cancer (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (326 citations), Pharmaceutical Science (51 citations) and Molecular Biology (437 citations). Huaixin Xing has collaborated with scholars based in China and United States. Frequent co-authors include Ming Yang, Nasha Zhang, Yemei Song, Mengyu Xie, Jibing Liu, Yingui Sun, Ling Wei, Xingwu Wang, Liyan Lv and Shuzhen Wang. Their work appears in journals such as PLoS ONE, Scientific Reports and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.